A profile of impaired insulin degradation in relation to late-life cognitive decline: A preliminary investigation

International Journal of Geriatric Psychiatry

Volumn 24, Issue 2, 2009, Pages 177-182

  Okereke, Olivia I ^a   Selkoe, Dennis J ^b   Pollak, Michael N ^c   Stampfer, Meir J ^a,d   Hu, Frank B ^a,d   Hankinson, Susan E ^a,d   Grodstein, Francine ^a,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Aging; Alzheimer disease; C peptide; Cognition; Insulin degrading enzyme

Indexed keywords

C PEPTIDE; INSULIN;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEGRADATION; INSULIN RELEASE; MAJOR CLINICAL STUDY; MEMORY DISORDER; MENTAL TEST; PHENOTYPE; PROTEIN BLOOD LEVEL; VERBAL MEMORY;

AGED; AGING; ALZHEIMER DISEASE; C-PEPTIDE; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; INSULIN; MALE; MEMORY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE;

EID: 67649372868     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2089     Document Type: Article

References (22)

1. Albert M, Smith LA, Scherr PA, et al. 1991. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci 57: 167-178.
2. Blomqvist ME, Chalmers K, Andreasen N, et al. 2005. Sequence variants of IDE are associated with the extent of β-amyloid deposition in the Alzheimer's disease brain. Neurobiol Aging 26: 795-802.
3. Brandt J, Spencer M, Folstein MF. 1988. The telephone interview for cognitive status. Neuropsych Neuropsychol Behav Neurol 1: 111-117.
4. Chen P, Ratcliff G, Belle SH, et al. 2000. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 55: 1847-1853.
5. Chen P, Ratcliff G, Belle SH, et al. 2001. Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry 58: 853-858.
6. Duckworth WC, Bennett RG, Hamel FG. Insulin degradation: progress and potential. Endocr Rev 19: 608-624.
7. Faber OK, Binder C, Markussen J, et al. 1978. Characterization of seven C-peptide antisera. Diabetes 27(Suppl 1): 170-177.
8. Farris W, Mansourian S, Chang Y, et al. 2003. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 100: 4162-4167.
9. Folstein MF, Folstein SE, McHugh PR. 1975. 'Mini-Mental State'. A. practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
10. Haffner SM, D'Agostino R, Saad MF, et al. 1996. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites: The Insulin Resistance Atherosclerosis Study. Diabetes 45: 742-748.
11. Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356.
12. Henriksen JH, Tronier B, Bülow JB. 1987. Kinetics of circulating endogenous insulin, c-peptide, and proinsulin in fasting nondiabetic man. Metabolism 36: 463-438.
13. Horwitz DL, Starr JI, Mako ME, et al. 1975. Proinsulin, insulin, and c-peptide concentrations in human portal and peripheral blood. J Clin Invest 55: 1278-1283.
14. Kang JH, Cook N, Manson J, et al. 2006. A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med 166: 2462-2468.
15. Kim M, Hersh LB, Leissring MA, et al. 2007. Decreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease families. J Biol Chem 282: 7825-7832.
16. Laird NM, Ware JH. 1982. Random-effects models for longitudinal data. Biometrics 38: 963-974.
17. McQueen MB, Bertram L, Lange C, et al. 2007. Exploring candidate gene associations with neuropsychological performance. Am J Med Genet B Neuropsychiatr Genet 144B: 987-991.
18. Mueller JC, Riemenschneider M, Schoepfer-Wendels A, et al. 2007. Weak independent association signals between IDE polymorphisms, Alzheimer's disease and cognitive measures. Neurobiol Aging 28: 727-734.
19. Nygren A, Adner N, Sundblad L,Wiechel KL. 1985. Insulin uptake by the human alcoholic cirrhotic liver. Metabolism 34: 48-52.
20. Okereke O, Hankinson SE, Hu FB, Grodstein F. 2005. Plasma C peptide level and cognitive function among older women without diabetes mellitus. Arch Intern Med 165: 1651-1656.
21. Polonsky KS, Rubenstein AH. 1984. C-peptide as a measure of the secretion and hepatic extraction of insulin: pitfalls and limitations. Diabetes 33: 486-494.
22. Wahren J, Ekberg K, Johansson J, et al. 2000. Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab 278: E759-768.